SaMD and Digital Therapeutics companies are transforming healthcare with software-based solutions that deliver therapeutic interventions, monitor patient health, or support clinical decision-making. These cutting-edge technologies require meticulous attention to user interface and experience, robust development, and clinical evaluation or validation strategies to meet unmet patient user needs, as well as regulatory, cybersecurity, and data privacy requirements.
Clinical evaluation for SaMD and digital therapeutics presents unique challenges, demanding a rigorous approach to demonstrate safety, efficacy, and usability, while ensuring patient data is protected through advanced cybersecurity measures.
Innovenn helps digital health innovators successfully navigate these challenges through:
- Medical device regulatory consulting
- FDA consulting and regulatory strategy
- Clinical and analytical validation services
- Human factors and usability engineering
- Privacy, security, and compliance
Innovenn provides comprehensive product development support to help deliver impactful, market-ready solutions, while our Human Factors’ affiliate, Improvita, provides tailored Human Factors (HF) and User Experience (UX) strategies to help these companies create intuitive, secure, and compliant solutions.
Together, we empower our clients to navigate the complexities of SaMD and digital therapeutics development, enabling them to bring innovative, evidence-based solutions to market with confidence.